* USANA Health Sciences Inc USNA.N USNA.K is expected
to show
a fall in quarterly revenue when it reports results on July
26.
* The Salt Lake City Utah-based company is expected to
report a
20.3% decrease in revenue to $268.449 million from $336.84
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for USANA Health
Sciences Inc
is for earnings of $1.14 per share. For the same quarter last
year, the company reported earnings of $1.87 per share.
* The current average analyst rating on the shares is "sell"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for USANA
Health
Sciences Inc is $74, above its last closing price of $69.21.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2022 1.14 1.14 1.15 Beat 0.9
Dec. 31 2022 1.28 1.28 1.03 Missed -19.5
Sep. 30 2021 1.30 1.30 1.36 Beat 4.6
Jun. 30 2021 1.71 1.72 1.87 Beat 9
Mar. 1.49 1.49 1.45 Missed -2.4
31 2021
Dec. 31 2020 1.43 1.43 1.87 Beat 31.1
Sep. 30 2020 1.27 1.27 1.44 Beat 13.8
Jun. 30 2020 1.10 1.08 1.32 Beat 22.2
This summary was machine generated July 23 at 02:03 GMT. All
figures in US dollars unless otherwise stated